首页 正文

Case Report: Personalized therapy in gynecological neuroendocrine neoplasm: a case of BRCA2-mutated ovarian neuroendocrine carcinoma treated with PARP-inhibitor

{{output}}
Introduction: Neuroendocrine neoplasms (NENs) of the female genital tract are rare and typically aggressive malignancies, accounting for only 1-2% of gynecologic tumors. The majority (54%) are located in the cervix. Ovarian neuro... ...